Neonc Technologies (NASDAQ:NTHI) CEO Amir Heshmatpour Purchases 12,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 12,000 shares of the business’s stock in a transaction on Friday, August 14th. The stock was purchased at an average cost of $3.79 per share, for a total transaction of $45,480.00. Following the completion of the acquisition, the chief executive officer directly owned 3,084,000 shares of the company’s stock, valued at approximately $11,688,360. The trade was a 0.39% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Neonc Technologies Stock Up 16.4%

Shares of NTHI stock opened at $4.91 on Tuesday. Neonc Technologies Holdings, Inc. has a 12-month low of $3.01 and a 12-month high of $12.99. The business’s fifty day simple moving average is $4.11 and its 200-day simple moving average is $6.05.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.46).

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on NTHI shares. Weiss Ratings lowered Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, June 24th. BTIG Research reissued a “buy” rating and set a $15.00 target price on shares of Neonc Technologies in a research report on Tuesday, May 26th. Wall Street Zen lowered shares of Neonc Technologies from a “hold” rating to a “sell” rating in a research note on Saturday. Alliance Global Partners assumed coverage on shares of Neonc Technologies in a report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price target for the company. Finally, Maxim Group began coverage on shares of Neonc Technologies in a report on Monday, May 18th. They issued a “buy” rating and a $20.00 price target for the company. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Neonc Technologies has an average rating of “Hold” and an average price target of $16.00.

Institutional Investors Weigh In On Neonc Technologies

A number of large investors have recently bought and sold shares of NTHI. HighPoint Advisor Group LLC increased its holdings in Neonc Technologies by 20.5% in the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock worth $9,466,000 after buying an additional 194,408 shares during the period. Bank of America Corp DE lifted its stake in Neonc Technologies by 5.0% during the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after acquiring an additional 11,108 shares during the period. Westmount Partners LLC boosted its holdings in shares of Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after acquiring an additional 153,858 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Neonc Technologies in the 2nd quarter valued at $815,000. Finally, Vanguard Group Inc. acquired a new stake in shares of Neonc Technologies in the third quarter worth $1,279,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.